NCT07896863Not yet recruiting
Mobile Clinic-Supported, Village Doctor-Led Screening and Integrated Care for Atrial Fibrillation and Heart Failure Comorbidity in Rural China (MOVE-AF HF)
Source: ClinicalTrials.gov · Last updated 27 Oct 2026
Brief summary (registry, in English)
AF and HF frequently coexist and are associated with poor clinical outcomes. In rural areas, limited access to echocardiography, NT-proBNP testing, and specialist care may hinder the early identification and appropriate management of HF among patients with AF. Mobile clinics may help overcome these barriers by bringing diagnostic testing and specialist support directly to rural communities. This cluster-randomized controlled trial aims to evaluate a mobile clinic-supported, village doctor-led model for HF screening and integrated management among older patients with AF in rural China. Mobile clinics equipped with echocardiography and NT-proBNP testing will support HF screening, and subsequent management will be tailored according to HF status. The study will evaluate whether this model can improve the detection of HF and reduce adverse cardiovascular events compared with routine management.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 1200 (estimated)
- First submitted
- 4 Oct 2026
- Start date
- 10 Oct 2026
- Primary completion date
- 30 Jun 2028
- Lead sponsor
- Jiangsu Taizhou People's Hospital
- Diseases
- Heart failure, Atrial fibrillation
- NCT number
- NCT07896863
What you commit to
- Study type: Interventional
- Planned participants: 1200
- From 10 Oct 2026 to the primary completion date, 30 Jun 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe renal insufficiency (Ccr \< 30ml/min) or ongoing dialysis treatment.
- Cardiac insufficiency secondary to correctable causes, including hyperthyroid heart disease, anemic heart disease, or uncorrected congenital heart disease.
- Chronic obstructive pulmonary disease (COPD) complicated by type II respiratory failure.
- Special populations, including patients with mental illnesses.
Other
- Expected life expectancy of less than 3 months.
- Indications for pacemaker implantation without having undergone implantation.
Who the study is looking for
- Permanent residents with local household registration at the primary level in Donghai County, aged ≥ 65 years;
- Electrocardiogram (ECG) confirmation of AF or possession of a diagnostic certificate for AF issued by a specialist;
- Management by a village clinic near the participant's place of residence;
- Ability to understand the study procedures and provide written informed consent.
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Donghai County People's Hospital Coordinator of this site? Confirm its status | Lianyungang | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.